GlassScriptPhysician profile
Lynn M Speaks
NPI 1710993605
$1,080.24
in general payments reported to CMS, 2019-2025
16 companies · $434 in 2025
The $434 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2021: $19.58 · 2022: $138 · 2023: $25.46 · 2024: $354 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $814.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $220.18 | 2022-2025 | Myosure Tissue Removal Device, Novasure |
| Astellas Pharma US INC | $134.30 | 2024-2025 | Veozah |
| Abbvie INC. | $122.92 | 2019-2024 | |
| Biogen, INC. | $120.56 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $105.78 | 2024-2025 | Slynd |
| Mayne Pharma Commercial LLC | $88.29 | 2024-2025 | |
| Mimedx Group, INC. | $45.68 | 2024-2025 | |
| Coopersurgical, INC. | $37.88 | 2025 | |
| Minerva Surgical, INC | $32.22 | 2024 | |
| Agile Therapeutics, INC. | $31.97 | 2024 | Twirla |
| Sumitomo Pharma America, INC. | $26.98 | 2024 | Myfembree |
| Pfizer INC. | $25.46 | 2023 | |
| Innovation Technologies INC | $24.46 | 2024 | Irrisept |
| Organon LLC | $22.74 | 2025 | Nexplanon |
| Medtronic, INC. | $21.24 | 2025 | Ligasure |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $19.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynn Speaks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.